Comprehensive Analysis of the Relationship between Cuproptosis-Related Gene GCSH and Prognosis, Tumor Microenvironment Infiltration, and Therapy Response in Endometrial Cancer
Oncology · 2024
DOI: 10.1159/000534018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology, 2024. Verfasst von Mengya Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecologic Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Endometrial Neoplasms, Glutamate-Cysteine Ligase. Die Arbeit wurde bisher 5-mal zitiert (Crossref).
Abstract (Originalsprache)
Introduction
Cuproptosis is a novel form of cell death regulated by protein lipoylation and implicated in mitochondrial metabolism. However, further research is needed to explore the influence of the cuproptosis-related gene γ-glutamylcysteine synthetase (GCSH) on the prognosis of endometrial cancer (EC), the tumor immune microenvironment, and therapeutic response.
Methods
The differential expression of GCSH between EC and normal tissues was analyzed using multiple public databases. Additionally, cancer and adjacent tissues were prospectively collected from 17 EC patients, and immunohistochemical analysis was performed to further investigate GCSH expression differences. The relationship between GCSH and the prognosis and clinicopathological characteristics of EC patients was evaluated, and a nomogram was constructed to predict patient survival based on GCSH expression. Subsequently, Gene set variation analysis was used to explore the potential biological functions of GCSH in EC. The impact of GCSH on the tumor microenvironment (TME) was estimated. Finally, the effect of GCSH on the response to immunotherapy and chemotherapeutic drugs in EC was investigated.
Results
The expression of GCSH was significantly upregulated in EC. High GCSH expression was associated with poor prognosis in EC patients. Enrichment analysis revealed an association between high GCSH and immune suppression. Furthermore, high GCSH was found to be associated with a non-inflamed TME, leading to decreased infiltration levels of immune cells. Lastly, it was observed that patients with high GCSH exhibited insensitivity to both immunotherapy and chemotherapeutic drugs.
Conclusion
This study revealed the role of GCSH in TME, response to therapy, and clinical prognosis in EC, which provided novel insights for the therapeutic application in EC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecologic Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
- Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China.
- Clinical Center and Key Lab of Intestinal and Colorectal Diseases of Hubei Province, Wuhan, China.
- Department of General Medical, Zhongnan Hospital of Wuhan University, Wuhan, China.
Zitieren
APA
Zhao, M., Nie, H., Qiu, P., Yu, Y., Wang, H., Wang, F., Fang, J., & Zhao, Q. (2024). Comprehensive Analysis of the Relationship between Cuproptosis-Related Gene GCSH and Prognosis, Tumor Microenvironment Infiltration, and Therapy Response in Endometrial Cancer. Oncology. https://doi.org/10.1159/000534018
Vancouver
Zhao M, Nie H, Qiu P, Yu Y, Wang H, Wang F, et al. Comprehensive Analysis of the Relationship between Cuproptosis-Related Gene GCSH and Prognosis, Tumor Microenvironment Infiltration, and Therapy Response in Endometrial Cancer. Oncology. 2024. doi:10.1159/000534018
BibTeX
@article{Zhao2024,
author = {Zhao, Mengya and Nie, Haihang and Qiu, Peishan and Yu, Yali and Wang, Haizhou and Wang, Fan and Fang, Jun and Zhao, Qiu},
title = {Comprehensive Analysis of the Relationship between Cuproptosis-Related Gene GCSH and Prognosis, Tumor Microenvironment Infiltration, and Therapy Response in Endometrial Cancer},
journal = {Oncology},
year = {2024},
doi = {10.1159/000534018}
}
EUVIMED